Zummo Jacqueline
CIK 0001798929
Chief R&D Officer
Filings
18
Latest Apr 9, 2026
Issuers covered
1
Showing
18 of 18
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 33% | -0.6% | -1.0% | +4.6% | -5.6% |
| 90 days | 1 | 100% | +32.5% | +32.5% | +32.5% | +32.5% |
| 180 days | 1 | 100% | +19.0% | +19.0% | +19.0% | +19.0% |
| 365 days | 1 | 0% | -14.6% | -14.6% | -14.6% | -14.6% |
Issuers
Companies where Zummo Jacqueline has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | 18 | Apr 9, 2026 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|